Area of research
Molecular Biology · Endocrinology, Diabetes and Metabolism
Research interest
Research focused on Osteoclast and RANKL, with related work in Osteoarthritis, Rosiglitazone, Gene expression. Notable publications include 'LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption', 'PGE2 activates EP4 in subchondral bone osteoclasts to regulate osteoarthritis', and 'PPARγ agonists delay age‐associated metabolic disease and extend longevity'.
Liquiritin in Aiduqing formula inhibits breast cancer neoangiogenesis by suppressing CTSK-mediated lysosomal degradation of CXCL1 in tumor-associated macrophages
PGE2 activates EP4 in subchondral bone osteoclasts to regulate osteoarthritis
PPARγ agonists delay age‐associated metabolic disease and extend longevity
ctcRbase: the gene expression database of circulating tumor cells and microemboli
LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption
The immunomodulatory effect of bone marrow stromal cells (BMSCs) on interleukin (IL)-23/IL-17-mediated ischemic stroke in mice